Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection.
about
Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolomeA computational approach to finding novel targets for existing drugsLocalized delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat brain using focused ultrasoundN-3 fatty acid rich triglyceride emulsions are neuroprotective after cerebral hypoxic-ischemic injury in neonatal miceLipids and lipidomics in brain injury and diseasesDocosahexaenoic acid pretreatment confers neuroprotection in a rat model of perinatal cerebral hypoxia-ischemia.Lipid-mediated cell signaling protects against injury and neurodegeneration.Docosahexaenoic acid neurolipidomics.Treatment of rat spinal cord injury with the neurotrophic factor albumin-oleic acid: translational application for paralysis, spasticity and pain.Treatment with docosahexaenoic acid after hypoxia-ischemia improves forepaw placing in a rat model of perinatal hypoxia-ischemiaDocosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and ischemiaDocosahexaenoic acid signaling modulates cell survival in experimental ischemic stroke penumbra and initiates long-term repair in young and aged rats.Docosahexaenoic Acid therapy of experimental ischemic stroke.Ischemic stroke and neuroprotection.Acute treatment with docosahexaenoic acid complexed to albumin reduces injury after a permanent focal cerebral ischemia in rats.Docosahexaenoic acid improves behavior and attenuates blood-brain barrier injury induced by focal cerebral ischemia in rats.Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammationDHA inhibits ER Ca2+ release and ER stress in astrocytes following in vitro ischemia.Potential for discovery of neuroprotective factors in serum and tissue from hibernating speciesSuperior Neuroprotective Efficacy of LAU-0901, a Novel Platelet-Activating Factor Antagonist, in Experimental Stroke.Enriched Endogenous Omega-3 Polyunsaturated Fatty Acids Protect Cortical Neurons from Experimental Ischemic Injury.Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oilDocosahexaenoic acid augments hypothermic neuroprotection in a neonatal rat asphyxia modelDocosahexaenoic acid confers neuroprotection in a rat model of perinatal hypoxia-ischemia potentiated by Escherichia coli lipopolysaccharide-induced systemic inflammation.Docosahexaenoic acid complexed to human albumin in experimental stroke: neuroprotective efficacy with a wide therapeutic windowDocosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model.Biochemical and biological functions of docosahexaenoic acid in the nervous system: modulation by ethanolIntegration of cytokine biology and lipid metabolism in strokeDocosanoids are multifunctional regulators of neural cell integrity and fate: significance in aging and disease.Role of Lipids in Brain Injury and Diseases.Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease.Multifunctional actions of approved and candidate stroke drugs.Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection.Pharmacotherapy of cerebral ischemia.Omega-3 fatty acids protect the brain against ischemic injury by activating Nrf2 and upregulating heme oxygenase 1.Fish oil diet associated with acute reperfusion related hemorrhage, and with reduced stroke-related sickness behaviors and motor impairment.Retinal light damage: mechanisms and protection.Role of Antioxidants in Neonatal Hypoxic-Ischemic Brain Injury: New Therapeutic Approaches.Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation.Supplementation of essential amino acids may reduce the occurrence of infections in rehabilitation patients with brain injury.
P2860
Q28387661-3DDC176F-4077-4B24-A1F3-1BC282BF8F30Q28476770-36EEC26F-01B2-4221-9113-110E852DAC29Q30362081-957950B3-6EA8-4191-A0E4-5D996735341CQ31111679-66598A10-79DF-4B17-A124-D031D481FF15Q33247769-F93ED07F-DD4E-43C0-B8D7-6CD2BED5EBA6Q33667312-D089A080-9E74-46A0-A041-3D8E0AC61BE6Q33727964-951076CD-E031-404D-BB35-EEB8A40483E3Q34002601-06B9708D-B883-4DAC-806E-5855FFFB0942Q34064354-9C4DE301-DD42-4ED9-ADBE-118662B52E82Q34163864-3CAE0591-B618-4525-A318-E43DFBA61CE1Q34363951-27687C7F-B654-4928-9FF5-905C668E90DBQ34464384-B6467F3C-920F-4C32-A691-701D82545B96Q34567799-2BB32322-776D-4FB6-BBBC-3973408C9997Q34601255-2660BB7E-FB58-4785-817B-9863FCB37D75Q35032398-1EAC59C0-DC5C-4828-9FB7-1BABA5FBC4A6Q35033401-B273471A-BA6B-4CF9-879F-FECA0A56FD2CQ35557372-AB765A19-80F6-41EF-A9B7-8AEF6D53FB09Q35675397-3CC27EB7-C918-49F4-80AE-43A2EB7D5A4BQ35679741-DBCB8ADA-3D3C-4DA9-819C-477459D4F235Q35772501-27157DDE-B59B-49A8-A567-959C2B648965Q35854060-27DBB388-176A-447B-9746-5C17F714C717Q36049510-B8E9DCCD-689A-4611-A823-DDA1679A2809Q36486153-FBA7F90A-0ADD-40EC-B8C2-D033C2E7AF52Q36503058-E44597C4-C612-45E4-951C-C07029C36285Q36517694-3B68A0E5-05AB-4621-AEA0-514D61BDB1CDQ36688749-77F25BAC-F3C6-4308-9BD0-E2F0A77861FCQ36839901-D157CF86-836F-4A52-B549-A96810101D3FQ36992077-FF9DC5FF-FCDE-4A2D-B8DD-533B1DF2DFEAQ37024930-4C1FC4D1-FA6E-425F-9348-30C55E267DE0Q37051065-7D234A8F-1089-44E1-8B84-27DABE5C6EEFQ37328906-B3C38FE9-99C9-45F1-A7E9-A109CFC92FCCQ37358654-645AD9D1-EE4C-4EAF-9AB2-B605FCBEBA71Q37374235-3BA98D84-04D5-490E-BC07-2B0AEA6C08FDQ37514167-A8F9F063-3112-43CA-A6A3-F3A4CEEF03F3Q37526130-4256F65B-3106-4FBD-9940-59579ECF6334Q37559450-262D3747-35B1-4869-BCE5-F04F63F9CBE5Q37642126-E8C8413F-A456-448E-8CC9-31D4026CDDB4Q37690680-DF971ADB-0551-4D67-9515-33DAE7B0E347Q37909028-74FF171A-182D-47B9-8B5F-525B2334EA14Q39656303-91282C42-E4F1-4F8A-8AA1-73E1DB29FC69
P2860
Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection.
@en
Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection.
@nl
type
label
Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection.
@en
Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection.
@nl
prefLabel
Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection.
@en
Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection.
@nl
P2093
P1433
P1476
Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection.
@en
P2093
Elena B Rodriguez de Turco
Larissa Khoutorova
Ludmila Belayev
Myron D Ginsberg
Nicolas G Bazan
Raul Busto
Victor L Marcheselli
P304
P356
10.1161/01.STR.0000149620.74770.2E
P407
P577
2004-11-29T00:00:00Z